Valmet (VALMT) Stock Surges 22% After Q2 Beat and Strategic Split Review
TLDR
- Valmet stock jumped as much as 28.9% to €28.42 on Friday, its highest intraday level since February 27
- Q2 net sales rose 6% to €1.32 billion, beating the highest analyst forecast of €1.27 billion
- Comparable EBITA rose 6% to €152 million, above the consensus of €140 million and topping the highest estimate of €150 million
- The board launched a strategic review to potentially split Biomaterial Solutions and Services and Process Performance Solutions into two separately listed companies on Nasdaq Helsinki
- Valmet reaffirmed 2026 guidance, targeting net sales at 2025’s level of €5.2 billion and Comparable EBITA at or above €620 million
Valmet stock surged as much as 28.9% to €28.42 on Friday, hitting its highest intraday level since February 27. The move came after the Finnish process technology group posted Q2 results that cleared analyst estimates across nearly every key metric.
Net sales for April-June rose 6% to €1.32 billion, up from €1.24 billion a year earlier. That beat both the average analyst estimate of €1.24 billion and the highest individual forecast of €1.27 billion compiled by Vara Research.
… Continue reading the full article at the original source below.
This content is automatically aggregated. Full credit goes to the original publisher (coincentral.com).
